Dark
Light
System
Institutional Investment Manager
PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC (CIK: 0001224962) incorporated in Delaware, located at 51 Astor Place, 10th Floor, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q1)
Portfolio Summary: 170 holdings with a total value of $1,140,104,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 AMICUS THERAPEUTICS INC 15,239,444 128,773,000 11.29%
2 NEUROCRINE BIOSCIE COM USD0.001 2,720,967 107,614,000 9.44%
3 SAREPTA THERAPEUTICS INC 3,833,128 74,823,000 6.56%
4 TESARO INC 1,098,659 48,374,000 4.24%
5 ALLERGAN PLC 155,000 41,545,000 3.64%
6 RETROPHIN INC COM 2,999,380 40,971,000 3.59%
7 XENCOR INC COM 1,804,784 24,220,000 2.12%
8 VERSARTIS INC COM 2,835,754 22,742,000 1.99%
9 ACCELERON PHARMA 803,036 21,192,000 1.86%
10 GLOBAL BLOOD THERAPEUTICS IN COM 1,297,468 20,577,000 1.80%
11 HUMANA 110,000 20,124,000 1.77%
12 NEVRO CORP 348,600 19,612,000 1.72%
13 QUOTIENT LTD 2,189,067 19,132,000 1.68%
14 ACELRX PHARMACEUTICALS INC 5,995,760 18,466,000 1.62%
15 FIVE PRIME THERAPEUTICS INC 454,129 18,451,000 1.62%
16 UNIQURE NV 1,442,093 17,132,000 1.50%
17 MEDIVATION INC 340,000 15,633,000 1.37%
18 LA JOLLA PHARMACEUTICAL CO 699,515 14,627,000 1.28%
19 Lion Biotechnologies 2,787,256 14,159,000 1.24%
20 TEVA PHARMACEUTICAL INDS LTD 261,000 13,966,000 1.22%
21 DBV TECHNOLOGIES 416,696 13,563,000 1.19%
22 VERTEX PHARMACEUT 160,000 12,718,000 1.12%
23 CELATOR PHARMACEUTICALS INC 1,100,000 12,133,000 1.06%
24 SAREPTA THERAPEUTICS INC 550,000 10,736,000 0.94% Call
25 DERMIRA INC 512,000 10,588,000 0.93%
26 CAPITAL SR LIVING CORP COM 544,636 10,087,000 0.88%
27 CYTOMX THERAPEUTICS INC COM 742,021 9,572,000 0.84%
28 PFENEX INC COM 960,877 9,446,000 0.83%
29 CIDARA THERAPEUTICS INC 742,858 9,434,000 0.83%
30 Alder Biopharmaceutl 375,000 9,184,000 0.81%
31 IGNYTA INC COM 1,347,060 9,119,000 0.80%
32 APPLIED GENETIC TECHNOL CORP 650,591 9,095,000 0.80%
33 DEPOMED INC 650,000 9,055,000 0.79%
34 Baxter Intl Inc 220,000 9,038,000 0.79%
35 REGENXBIO INC COM 825,396 8,914,000 0.78%
36 ZYNERBA PHARMACEUTICALS INC 849,350 8,026,000 0.70%
37 AKEBIA THERAPEUTICS INC 865,000 7,794,000 0.68%
38 VBI Vaccines Inc. 3,260,356 7,661,000 0.67%
39 EAGLE PHARMACEUTICALS INC COM 187,215 7,582,000 0.67%
40 VERICEL CORP 1,247,312 7,310,000 0.64%
41 BLUEPRINT MEDICINES CORP COM 404,404 7,299,000 0.64%
42 Baxter Intl Inc 175,400 7,168,000 0.63% Call
43 PSIVIDA CORP 2,665,000 7,142,000 0.63%
44 ACADIA PHARMACEUTICALS INC COM 255,240 7,137,000 0.63%
45 NEPTUNE TECHNOLOGIES BIORESO 6,750,444 6,750,000 0.59%
46 ANI PHARMACEUTICALS INC 7,500,000 6,590,000 0.58% PRN
47 Evolent Health, Inc. 618,930 6,536,000 0.57%
48 NOVO-NORDISK A S 116,660 6,322,000 0.55%
49 MIRATI THERAPEUTICS INC COM 273,000 5,842,000 0.51%
50 HORIZON PHARMA PLC 350,000 5,800,000 0.51%
Page 1 of 4

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019056-16-001336, filed 2016.05.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.